Researchers have identified the structure of the human type 2 cannabinoid receptor. The findings, researchers say, can help in the development of new treatments for inflammatory and neurodegenerative diseases.
A new study reveals how dangerous inflammations in the brain are caused during the aging process. Researchers say failure with the CB1 to control activity of immune cells may result in chronic neuroinflammation. They say it may be possible to break this vicious cycle in the future with drugs that contain THC, which is a powerful CB1 receptor activator.
Researchers report low doses of THC can help restore memory and reverse some of the effects of brain aging in mice. The findings could open new avenues for treating dementia and other neurodegenerative diseases.